investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The Role of Cancer Stem Cells in Liver Cancer Heterogeneity and Subtypes
Xin Wei Wang
7 Collaborator(s)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Zhao-You Tang
Shanghai Cancer Institute
Shanghai, China
Qinghai Ye
Shanghai Cancer Institute
Shanghai, China
Hui-Chuan Sun
Shanghai Cancer Institute
Shanghai, China
Takahiro Uenishi
Osaka City University
Osaka, Japan
Shuichi Kaneko
Kanazawa University
Kanazawa, Japan
Lun-Xiu Qin
Fudan University
Shanghai, China
Hiromitsu Nakauchi
University of Tokyo
Tokyo, Japan
Xin Wei Wang
National Cancer Institute (NIH)
Rockville, United States
Related projects
John Tavis
HBV Drug Development
Liver and intrahepatic bile ducts
Pathology
Xin Wei Wang
Molecular Signatures for Liver Cancer Diagnosis and Treatment Stratification
Liver and intrahepatic bile ducts
Pathology
Frank Gonzalez
Xenobiotic Receptors – Rockville
Liver and intrahepatic bile ducts
Pathology
Snorri Thorgeirsson
Genomic Classification of Human Liver Cancer
Liver and intrahepatic bile ducts
Pathology
Mitchell Ho
Development of antibody-based cancer therapies
Liver and intrahepatic bile ducts
Pathology
Frank Gonzalez
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers – Rockville
Liver and intrahepatic bile ducts
Pathology
Geoffrey D Girnun
Metabolic control of hepatocellular carcinoma by PGC1alpha
Liver and intrahepatic bile ducts
Pathology
J H James Ou
HBV Replication and Carcinogenesis
Liver and intrahepatic bile ducts
Pathology
Lewis R Roberts
Regulation of the Tumor Microenvironment in Hepatocellular Carcinoma
Liver and intrahepatic bile ducts
Pathology
